N-{´(2S)-4-(3,4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl)amino!phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions
A Standard patent application filed on 27 March 2003 credited to Walker, Andrew John ; Lewell, Xiao Qing ; Eldred, Colin David ; Judd, Duncan Bruce ; Mills, Gail ; Robertson, Graeme Michael ; Harrison, Lee Andrew ; Wilkinson, Mark ; Hayes, Martin Alistair ; Gore, Paul Martin ; Ancliff, Rachael Ann

Details

Application number :
2003216905  
Application type :
Standard  
Application status :
LAPSED  
Under opposition :
No  
Proceeding type :
 
Invention title :
N-{´(2S)-4-(3,4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl)amino!phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions  
Inventor :
Walker, Andrew John ; Lewell, Xiao Qing ; Eldred, Colin David ; Judd, Duncan Bruce ; Mills, Gail ; Robertson, Graeme Michael ; Harrison, Lee Andrew ; Wilkinson, Mark ; Hayes, Martin Alistair ; Gore, Paul Martin ; Ancliff, Rachael Ann  
Agent name :
Phillips Ormonde Fitzpatrick  
Address for service :
367 Collins Street Melbourne VIC 3000 Australia  
Filing date :
27 March 2003  
Associated companies :
 
Applicant name :
Glaxo Group Limited  
Applicant address :
Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN United Kingdom  
Old name :
 
Original Source :
Go  

Same Inventor